These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32016852)

  • 1. Effect of new olivacine derivatives on p53 protein level.
    Gębarowski T; Wiatrak B; Gębczak K; Tylińska B; Gąsiorowski K
    Pharmacol Rep; 2020 Feb; 72(1):214-224. PubMed ID: 32016852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor Activity of New Olivacine Derivatives.
    Piasny J; Wiatrak B; Dobosz A; Tylińska B; Gębarowski T
    Molecules; 2020 May; 25(11):. PubMed ID: 32481577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Interactions of Selected Olivacine Derivatives with DNA and Topoisomerase II.
    Tylińska B; Dobosz A; Spychała J; Cwynar-Zając Ł; Czyżnikowska Ż; Kuźniarski A; Gębarowski T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pyridocarbazole derivatives. Synthesis and their in vitro anticancer activity.
    Jasztold-Howorko R; Tylińska B; Biaduń B; Gebarowski T; Gasiorowski K
    Acta Pol Pharm; 2013; 70(5):823-32. PubMed ID: 24147360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal Exocytosis of Olivacine on the Way to Explain Drug Resistance in Cancer Cells.
    Wiatrak B; Gębarowski T; Czwojdziński E; Gąsiorowski K; Tylińska B
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of mutant p53 transcription function by ellipticine.
    Peng Y; Li C; Chen L; Sebti S; Chen J
    Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
    Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
    J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
    Savorani C; Manfé V; Biskup E; Gniadecki R
    Leuk Lymphoma; 2015 Mar; 56(3):739-47. PubMed ID: 24898668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationship analysis of new olivacine derivatives.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Kłopotowska D; Filip B; Wietrzyk J
    Acta Pol Pharm; 2010; 67(5):495-502. PubMed ID: 20873417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.
    Wang JP; Yu YC; Chen SP; Liang HC; Lin CW; Fang K
    Mol Cell Biochem; 2015 Sep; 407(1-2):123-33. PubMed ID: 26014912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells.
    Fang K; Chen SP; Lin CW; Cheng WC; Huang HT
    Lung Cancer; 2009 Feb; 63(2):227-34. PubMed ID: 18619705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S16020 Pyridocarbazole Derivatives Display High Activity to Lung Cancer Cells.
    Chabowska G; Moreira H; Tylińska B; Barg E
    Anticancer Agents Med Chem; 2022; 22(13):2419-2428. PubMed ID: 34906061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships.
    Ferlin MG; Marzano C; Gandin V; Dall'Acqua S; Dalla Via L
    ChemMedChem; 2009 Mar; 4(3):363-77. PubMed ID: 19197924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembling peptide-based nanoparticles enhance anticancer effect of ellipticine in vitro and in vivo.
    Wu Y; Sadatmousavi P; Wang R; Lu S; Yuan YF; Chen P
    Int J Nanomedicine; 2012; 7():3221-33. PubMed ID: 22802684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives.
    Mori R; Kato A; Komenoi K; Kurasaki H; Iijima T; Kawagoshi M; Kiran YB; Takeda S; Sakai N; Konakahara T
    Eur J Med Chem; 2014 Jul; 82():16-35. PubMed ID: 24863982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Styryl-4-aminoquinazoline derivatives as potent DNA-cleavage, p53-activation and in vivo effective anticancer agents.
    Wei XW; Yuan JM; Huang WY; Chen NY; Li XJ; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2020 Jan; 186():111851. PubMed ID: 31761381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
    Punganuru SR; Madala HR; Venugopal SN; Samala R; Mikelis C; Srivenugopal KS
    Eur J Med Chem; 2016 Jan; 107():233-44. PubMed ID: 26599530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 mediated induction of cell cycle arrest and apoptosis at G1 phase by 9-hydroxyellipticine.
    Sugikawa E; Hosoi T; Yazaki N; Gamanuma M; Nakanishi N; Ohashi M
    Anticancer Res; 1999; 19(4B):3099-108. PubMed ID: 10652599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of new 1-phenyl-6H-pyrido[4,3-b]carbazole derivatives with potential cytostatic activity.
    Tylińska B; Jasztold-Howorko R; Mastalarz H; Szczaurska-Nowak K; Materek P; Wietrzyk J
    Acta Pol Pharm; 2011; 68(1):31-7. PubMed ID: 21485699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.